S&P MidCap 400 Pure Growth Fund ROIV Holdings History
S&P MidCap 400 Pure Growth Fund's Roivant Sciences Ltd Holding Summary
As of 2025-03-31, RYDEX SERIES FUNDS held 54,230.00 shares of Roivant Sciences Ltd(ROIV), totaling $547,180.00. This investment constitutes 2.18% of their stock portfolio, and RYDEX SERIES FUNDS now holds 0.01% of the outstanding Roivant Sciences Ltd(ROIV) stock.
The initial trade took place in 2024Q4. And since then S&P MidCap 400 Pure Growth Fund has made 1 purchases of ROIV, at an average price of $11.83, for a total of 61,320.00 shares. In addition, there have been 1 sales at an average price of $10.81 for 7,090.00 shares. Based on historical transaction data and ROIV's current price of $11.44, S&P MidCap 400 Pure Growth Fund's estimated gain on his ROIV holdings is $-28,381.50, reflecting a -3.91% gain to date.
S&P MidCap 400 Pure Growth Fund ROIV ($11.44) Holding Chart
S&P MidCap 400 Pure Growth Fund ROIV ($11.44) Quarterly Buys and Sells
Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
---|---|---|---|---|
Shares Bought | 0 | Average Price $-/Share | ||
Shares Sold | 0 | Average Price $-/Share | ||
Current Price $0.00 | Total Estimated Gain 0 % |
Top Ranked Articles
- 1